From: The transcriptional profile of coronary arteritis in Kawasaki disease
Case # | Time since onset | KD therapy | Category | Pathology study case # [4] | RNA tested by |
---|---|---|---|---|---|
KD1 | 2.5Â weeks | None | Untreated | 4 | HTS, PCR |
KD2 | 4Â weeks | ASA, dipyridamole | Untreated | 16 | HTS |
KD3 | 5Â months | None | Untreated | 26 | HTS, PCR |
KD4 | 7Â months | None | Untreated | NA | HTS, PCR |
KD5 | 3.5Â weeks | IGIV, ASA, steroid | Treated | 11 | HTS, PCR |
KD6 | 4Â weeks | IGIV, ASA, steroid, infliximab | Treated | 13 | HTS, PCR |
KD7 | 3Â weeks | IGIV, ASA | Treated | 7 | HTS, PCR |
KD8 | 5Â weeks | IGIV, ASA, steroid | Treated | 18 | HTS |